IPR Tracker: IPR2016-00408 and IPR2016-00409 (Boehringer Ingelheim) (U.S. Patent No. 8,889,135)

PTAB + IPR

IPR2016-00408 (Boehringer Ingelheim) (U.S. Patent No. 8,889,135)

  • Petitioner: Boehringer Ingelheim Corp., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp.
  • Patent: U.S. Patent No. 8,889,135
  • Patent Title: Methods of Administering Anti-TNFα Antibodies
  • Patent Owner: AbbVie Biotechnology Ltd.

IPR2016-00409 (Boehringer Ingelheim) (U.S. Patent No. 8,889,135)

  • Petitioner: Boehringer Ingelheim Corp., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp.
  • Patent: U.S. Patent No. 8,889,135
  • Patent Title: Methods of Administering Anti-TNFα Antibodies
  • Patent Owner: AbbVie Biotechnology Ltd.
Download PDF

Comments are closed.